Clinical Trial Update: WATCHMAN Left Atrial Appendage System for Embolic PROTECTion in Patients With Atrial Fibrillation [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update for the WATCHMAN Left Atrial Appendage System in atrial fibrillation reports completed Phase 2 and Phase 3 PROTECT trials with results pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Stroke

Drugs mentioned

• WATCHMAN Left Atrial Appendage System

Snippet

Sponsor: Boston Scientific Corporation | Conditions: Atrial Fibrillation, Stroke | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2015-05-15